Jonathan Alspaugh

Insider Reports History

Entity
Individual
Location
C/O Aeglea Biotherapeutics, Inc., 805 Las Cimas Parkway, Suite 100, Austin, TX
Signature
/s/ Jonathan Alspaugh
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Alspaugh:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aeglea BioTherapeutics, Inc. President and CFO Employee Stock Option (right to buy) 19.8M Jun 22, 2023 Direct

Insider Reports Filed by Jonathan Alspaugh

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AGLE Aeglea BioTherapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 30, 2023 President and CFO
AGLE Aeglea BioTherapeutics, Inc. Feb 23, 2023 1 $0 4 Feb 24, 2023 Chief Financial Officer
AGLE Aeglea BioTherapeutics, Inc. Aug 23, 2022 1 $0 4 Aug 25, 2022 Chief Financial Officer
AGLE Aeglea BioTherapeutics, Inc. Mar 11, 2022 1 $156K 4 Mar 15, 2022 Chief Financial Officer
AGLE Aeglea BioTherapeutics, Inc. Feb 17, 2022 1 $0 4 Feb 22, 2022 Chief Financial Officer
AGLE Aeglea BioTherapeutics, Inc. Dec 9, 2021 1 $186K 4 Dec 13, 2021 Chief Financial Officer
AGLE Aeglea BioTherapeutics, Inc. Aug 16, 2021 3 $263K 4 Aug 18, 2021 Chief Financial Officer
AGLE Aeglea BioTherapeutics, Inc. Jul 6, 2021 1 $0 4 Jul 8, 2021 Chief Financial Officer
AGLE Aeglea BioTherapeutics, Inc. Jul 6, 2021 0 $0 3 Jul 8, 2021 Chief Financial Officer